Phosphatidlyinositol-3-kinase C2 beta (PI3KC2β) is a potential new target to treat IgE mediated disease

about

Phosphatidlyinositol-3-kinase C2 beta (PI3KC2β) is a potential new target to treat IgE mediated disease

Item

http://www.wikidata.org/entity/Q41456099

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Phosphatidlyinositol-3-kinase ...... to treat IgE mediated disease

@en

type

Item

label

Phosphatidlyinositol-3-kinase ...... to treat IgE mediated disease

@en

prefLabel

Phosphatidlyinositol-3-kinase ...... to treat IgE mediated disease

@en

P1476

Phosphatidlyinositol-3-kinase ...... to treat IgE mediated disease

@en

P2093

Edward Y Skolnik

http://www.w3.org/2001/XMLSchema#string

Zhai Li

http://www.w3.org/2001/XMLSchema#string

P2860

Tripartite motif containing protein 27 negatively regulates CD4 T cells by ubiquitinating and inhibiting the class II PI3K-C2β

Essential role for the p110delta phosphoinositide 3-kinase in the allergic response

PIK3C2B inhibition improves function and prolongs survival in myotubular myopathy animal models

Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis

PI3K class II α controls spatially restricted endosomal PtdIns3P and Rab11 activation to promote primary cilium function

The class II phosphoinositide 3-kinase C2beta is not essential for epidermal differentiation

Nucleoside diphosphate kinase B knock-out mice have impaired activation of the K+ channel KCa3.1, resulting in defective T cell activation.

Involvement of class II phosphoinositide 3-kinase α-isoform in antigen-induced degranulation in RBL-2H3 cells.

Inactivation of the Class II PI3K-C2β Potentiates Insulin Signaling and Sensitivity

Ion channels in innate and adaptive immunity

P304

e0183474

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0183474

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shekhar Srivastava

P577

2017-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28820911

http://www.w3.org/2001/XMLSchema#string

P932

5562315

http://www.w3.org/2001/XMLSchema#string

Phosphatidlyinositol-3-kinase C2 beta (PI3KC2β) is a potential new target to treat IgE mediated disease

about

Phosphatidlyinositol-3-kinase C2 beta (PI3KC2β) is a potential new target to treat IgE mediated disease

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932